Innovate Blog
What the Biden Administration’s Drug Pricing Reforms Mean for Employers
Policy specialists taking part in a recent PBGH roundtable on drug costs noted the reforms continue to enjoy broad, bi-partisan support and will help address a top concern of the American people in an election year.
Employers Are Driving Innovations in Primary Care
Large employers are increasingly working with existing direct contracting partners and new vendors to enhance primary care, which includes, among other things, the integration of behavioral health care.
5 Federal Policies for Employers to Watch in 2022
With the country in its fifth wave of coronavirus cases and hospitals full to the point of breaking, the ongoing pandemic clouds and shapes the health policy landscape.
Looking Toward the Horizon: Top 7 Health Care Trends for Employers in 2022
At the recent PBGH year-end roundtable, noted health care futurist Ian Morrison discussed key health care trends that both he and PBGH believe will be most relevant to purchasers in the year ahead.
Top 10 PBGH Innovate Blog Posts of 2021
The PBGH Innovate blog features articles written by PBGH and other experts about drug prices and fights over legislation to reign them in, health care market consolidation, payment reform, surprise medical bills, hospital price transparency, advanced primary care and beyond.
A Little Less Conversation, A Little More Action
Large employers and health care purchasers have increasingly begun to take actionable steps to strengthen primary care, the critical precursor to a high-quality, cost-effective health care system.
Price Transparency Offers Opportunity to Employers and Purchasers
A landmark federal rule requires the nation’s 6,000 hospitals to make pricing data available publicly. This requirement includes plan-specific negotiated prices, not just the “chargemaster” prices, for every item or service.
Congress Must Keep Its Promise to Lower Drug Costs for All Americans
If the reconciliation bill currently being debated in Congress includes Medicare-only drug price limits, the 180 million Americans with private health coverage would be left behind.
Seeing Through Pharma’s “Free Market” Façade
Here’s the problem with the drug industry’s top talking point: It’s a lie.
Using Primary Care’s Potential to Improve Health Outcomes
Through successive initiatives and in collaboration with a diverse group of committed stakeholders, PBGH has spearheaded efforts to create a blueprint for “advanced primary care.”
